The Biden administration today announced a $1.6 billion investment to expand COVID-19 testing, increase manufacturing of testing supplies and spur virus genome sequencing. 

The investment is described by the White House as a pilot program administered by the departments of Health and Human Services and Defense that will serve as a bridge until Congress delivers more funds through a relief bill. It includes:

  • $650 million to expand testing in schools and underserved congregate settings, such as homeless shelters;
  • $815 million to increase domestic manufacturing for testing-related supplies and raw materials, including filter pipette tips, nitrocellulose used in antigen point-of-care tests, and specific injected molded plastics needed to house testing reagents; and
  • nearly $200 million for Centers for Disease Control and Prevention-led efforts to identify, track and mitigate emerging strains of SARS-CoV-2 through genome sequencing.

Related News Articles

News
Long-term acute care hospitals have played a critical role during the COVID-19 public health emergency, partnering with short-term acute care hospitals to…
#HealthCareInnovation Thursday Blog
I remember where I was in March 2020, the moment our system had its first Incident Command System call. My family was watching a play in Indianapolis — about…
Headline
The public health emergency will likely remain in place through 2021, and the administration will give states 60 days’ notice before it decides to terminate…
Headline
As COVID-19 surges continue, lessons learned by health systems large and small reveal the importance of teamwork, communication, flexibility, preparation and…
#HealthCareInnovation Thursday Blog
If you’re like me and have been tracking the media over the past several months, then you have seen dozens of examples of rural health care leaders…
Headline
As the COVID-19 pandemic entered our country, hospitals and clinicians faced something never seen before. We quickly and significantly altered the playbook for…